X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (730) 730
oncology (683) 683
immunotherapy (680) 680
anti-pd-1 (665) 665
humans (580) 580
nivolumab (441) 441
melanoma (413) 413
cancer (411) 411
anti-pd-1 antibody (357) 357
ipilimumab (354) 354
safety (326) 326
pembrolizumab (296) 296
immunology (258) 258
female (232) 232
metastatic melanoma (209) 209
pd-1 (206) 206
care and treatment (201) 201
chemotherapy (199) 199
male (196) 196
metastasis (191) 191
tumors (187) 187
blockade (180) 180
middle aged (179) 179
aged (172) 172
programmed cell death 1 receptor - antagonists & inhibitors (167) 167
open-label (166) 166
patients (159) 159
apoptosis (157) 157
therapy (155) 155
animals (151) 151
survival (147) 147
antibodies, monoclonal - therapeutic use (144) 144
cancer therapies (140) 140
lymphocytes (140) 140
melanoma - drug therapy (134) 134
pd-l1 (134) 134
antineoplastic agents - therapeutic use (131) 131
immune checkpoint (128) 128
expression (127) 127
adult (126) 126
advanced melanoma (125) 125
clinical trials (122) 122
research (122) 122
anti-pd-1 therapy (121) 121
antibody (121) 121
pd-1 blockade (120) 120
lung cancer (119) 119
analysis (117) 117
programmed cell death 1 receptor - immunology (114) 114
cell lung-cancer (110) 110
immunotherapy - methods (110) 110
treatment outcome (109) 109
t-cells (105) 105
t cells (103) 103
antibodies, monoclonal - adverse effects (102) 102
pd-1 protein (102) 102
immune checkpoint inhibitors (98) 98
medicine, research & experimental (97) 97
antibodies (96) 96
docetaxel (94) 94
review (93) 93
cell death (92) 92
anti-ctla-4 (90) 90
aged, 80 and over (89) 89
health aspects (89) 89
antineoplastic agents - adverse effects (88) 88
drug therapy (84) 84
prognosis (82) 82
adverse events (81) 81
antigens (81) 81
article (81) 81
melanoma - pathology (78) 78
ligands (77) 77
antibodies, monoclonal, humanized - therapeutic use (76) 76
b7-h1 antigen - antagonists & inhibitors (76) 76
neoplasms - immunology (76) 76
lymphocytes t (74) 74
pharmacology & pharmacy (74) 74
medical prognosis (73) 73
cytotoxicity (71) 71
cell biology (70) 70
lung cancer, non-small cell (69) 69
mice (69) 69
usage (69) 69
immune response (67) 67
toxicity (67) 67
responses (66) 66
skin neoplasms - drug therapy (66) 66
antibodies, monoclonal, humanized - adverse effects (65) 65
biomarkers (65) 65
medical research (65) 65
neoplasms - drug therapy (65) 65
metastases (64) 64
respiratory system (64) 64
ctla-4 (63) 63
immune checkpoint blockade (63) 63
medicine & public health (63) 63
pd-l1 protein (63) 63
tumor-infiltrating lymphocytes (63) 63
melanoma - immunology (62) 62
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1256) 1256
French (25) 25
German (13) 13
Korean (4) 4
Slovenian (2) 2
Polish (1) 1
Russian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 10/2018, Volume 24, Issue 20, pp. 4960 - 4967
Purpose: The purpose of this study was to assess the association of baseline tumor size (BTS) with other baseline clinical factors and outcomes in... 
VERSION | THERAPY | ANTI-PD-1 | ONCOLOGY | IPILIMUMAB
Journal Article
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 03/2018, Volume 378, Issue 12, pp. 1163 - 1164
Journal Article
European Journal of Cancer, ISSN 0959-8049, 12/2017, Volume 87, pp. 216 - 218
Journal Article
American Journal of Clinical Oncology: Cancer Clinical Trials, ISSN 0277-3732, 11/2018, Volume 41, Issue 11, pp. 1083 - 1088
Journal Article
European Journal of Cancer, ISSN 0959-8049, 05/2018, Volume 95, pp. 130 - 132
Journal Article
International Journal of Dermatology, ISSN 0011-9059, 06/2019, Volume 58, Issue 6, pp. 736 - 738
Journal Article
DIABETES, ISSN 0012-1797, 08/2018, Volume 67, Issue 8, pp. 1471 - 1480
Insulin-dependent diabetes may occur in patients with cancers who are treated with checkpoint inhibitors (CPIs). Wereviewed cases occurring over a 6-year... 
ANTIBODIES | AUTOIMMUNE | THERAPY | IMMUNOTHERAPY | ENDOCRINE | ENDOCRINOLOGY & METABOLISM | DISORDERS | CTLA-4 | KETOACIDOSIS | ANTI-PD-1 | ADVERSE EVENTS
Journal Article
ONCOLOGY RESEARCH AND TREATMENT, ISSN 2296-5270, 2018, Volume 41, pp. 45 - 45
Conference Proceeding
Clinical Cancer Research, ISSN 1078-0432, 09/2018, Volume 24, Issue 17, pp. 4059 - 4061
Patients with glioblastoma (GBM) exhibit a complex state of immune dysfunction involving multiple mechanisms of local, regional, and systemic immunosuppression... 
GLIOMAS | THERAPY | ANTI-PD-1 | ONCOLOGY | CANCER | PD-1 BLOCKADE
Journal Article
Annals of Oncology, ISSN 0923-7534, 03/2019, Volume 30, Issue 3, pp. 397 - 404
Abstract Background Treatment options for previously treated metastatic triple-negative breast cancer (mTNBC) are limited. In cohort A of the phase II... 
pembrolizumab | triple-negative breast neoplasms | anti-PD-1 | immunotherapy | ONCOLOGY | PD-L1 EXPRESSION | ANTIBODY
Journal Article
European Journal of Cancer, ISSN 0959-8049, 03/2019, Volume 110, pp. 8 - 10
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 10/2018, Volume 179, Issue 4, pp. 993 - 994
Journal Article
Cancer Epidemiology Biomarkers and Prevention, ISSN 1055-9965, 12/2014, Volume 23, Issue 12, pp. 2965 - 2970
Cancer cells expressing PD-1 ligands (PD-L1/PD-L2) inhibit immune-modulatory T-cell activation facilitating disease progression. Preliminary clinical trials... 
SURVIVAL | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | B7-H1 PD-L1 | MELANOMA | ONCOLOGY | SAFETY | POOR-PROGNOSIS | ANTI-PD-1 | HUMAN BREAST-CANCER | EXPRESSION | CARCINOMA | LYMPHOCYTES | Prognosis | Neoplasms - genetics | Humans | Female | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Disease Progression | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 10, pp. 1020 - 1030
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2015, Volume 373, Issue 17, pp. 1627 - 1639
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.